A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy

This study aimed to examine the efficacy of epirubicin-loaded gelatin hydrogel (EPI-H) in the treatment of superficial urothelium carcinoma. Hydrogel was prepared by Schiff base-crosslinking of gelatin with glutaraldehyde. EPI-H exhibited high entrapment efficiency (59.87% ± 0.51%). EPI-H also incre...

Full description

Bibliographic Details
Main Authors:	Ching-Wen Liu, Yu-Tse Wu, Kai-Jen Lin, Tsan-Jung Yu, Yu-Liang Kuo, Li-Ching Chang
Format:	Article
Language:	English
Published:	MDPI AG 2016-06-01
Series:	Molecules
Subjects:	epirubicin hydrogel intravesical bladder cancer
Online Access:	http://www.mdpi.com/1420-3049/21/6/712

Similar Items

Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
by: J. Liu, et al.
Published: (2024-01-01)

Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration
by: Xingjian Zhang, et al.
Published: (2023-09-01)

Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study
by: Wei Phin Tan, et al.
Published: (2020-01-01)

Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01)

Intravesical adriamycin in the management of bladder tumours Enugu experience
by: Aloy E Aghaji, et al.
Published: (1996-01-01)

Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer
by: Suo N, et al.
Published: (2019-02-01)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
by: Bedeir Ali-El-Dein, et al.
Published: (2013-01-01)

Effect of Epirubicin Against Glioma Initiating Cells
by: Atsushi Nakajima, et al.
Published: (2020-11-01)

Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy
by: Ting-Yu Chen, et al.
Published: (2020-10-01)

Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy
by: Li Jing, et al.
Published: (2023-12-01)

Gel-Based Nanocarrier for Intravesical Chemotherapy Delivery: In Vitro and In Vivo Study
by: Ting-Yu Chen, et al.
Published: (2020-10-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
by: Yilei Lu, et al.
Published: (2022-05-01)

Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer
by: Cheng‐Che Chen, et al.
Published: (2023-03-01)

The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment
by: Chong Yu, et al.
Published: (2023-01-01)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
by: Kang Liu, et al.
Published: (2020-02-01)

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
by: Hye Sung Won, et al.
Published: (2020-11-01)

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
by: Qiang Ruan, et al.
Published: (2021-02-01)

Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review
by: Zheng Wang, et al.
Published: (2023-10-01)

Intravesical Explosion Resulting in Bladder Rupture During Transurethral Resection of Bladder Tumors
by: Chih-Chiao Lee, et al.
Published: (2014-12-01)

Interstitial pneumonitis secondary to intravesical bacillus calmette-guerin for carcinoma in-situ of the bladder
by: Eric K. Diner, et al.
Published: (2004-10-01)

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
by: Samantha Conroy, et al.
Published: (2023-05-01)

Intravesical Contrast-Enhanced MRI: A Potential Tool for Bladder Cancer Surveillance and Staging
by: Pradeep Tyagi, et al.
Published: (2023-04-01)

3-year experience of hyperthermic intravesical chemotherapy use in patients with high risk non-muscular-invasive bladder cancer
by: R.S. Chystiakov, et al.
Published: (2023-06-01)

Implantable Devices for Sustained, Intravesical Drug Delivery
by: Seung Ho Lee, et al.
Published: (2016-06-01)

Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma
by: Tan H, et al.
Published: (2021-12-01)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
by: Mi Ah Han, et al.
Published: (2021-11-01)

Intravesical Instillation of Norketamine, a Ketamine Metabolite, and Induced Bladder Functional Changes in Rats
by: Chung-Hsin Yeh, et al.
Published: (2021-06-01)

Intravesical Sodium Chondroitin Sulphate to Treat Overactive Bladder: Preliminary Result
by: Lokman Irkilata, et al.
Published: (2015-06-01)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
by: Thiru Prasanna, et al.
Published: (2017-11-01)

Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
by: Javier Pérez Quiñones, et al.
Published: (2022-01-01)

The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery
by: Lisa Schmitz, et al.
Published: (2020-10-01)

Intravesical Agents in the Treatment of Bladder Clots in Children
by: Marcello Della Corte, et al.
Published: (2023-04-01)

The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
by: Jian-Xin Chen, et al.
Published: (2023-10-01)

Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A
by: Qinggang Liu, et al.
Published: (2022-06-01)

The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study
by: Zhongbao Zhou, et al.
Published: (2021-05-01)

Primary intravesical insertion of intrauterine device for 10 years: Clinical presentation and outcome
by: Rola Abu Alwafa, et al.
Published: (2024-03-01)

Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer
by: Iris S. G. Brummelhuis, et al.
Published: (2023-12-01)

Dispositivo intrauterino intravesical en expulsión en embarazo de tercer trimestre: reporte de un caso
by: Ernesto Perucca P, et al.
Published: (2011-01-01)

Mucoadhesive Polymers and Their Applications in Drug Delivery Systems for the Treatment of Bladder Cancer
by: Caroline S. A. de Lima, et al.
Published: (2022-09-01)